MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LRMR has $208,511K in assets. $50,478K in debts. $177,913K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
429.21%
Quick Ratio
429.21%
Cash Ratio
372.54%
Debt to Asset Ratio
24.21%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
177,913 85,412 90,140 20,587
Marketable securities
22,472 51,440 85,295 117,937
Prepaid expenses and other current assets
4,592 5,170 7,788 7,032
Total current assets
204,977 142,022 183,223 145,556
Fixed assets, gross
2,515 2,515 2,515 -
Less accumulated depreciation
1,957 1,893 1,806 -
Property and equipment, net
558 622 709 797
Operating lease right-of-use assets
1,866 2,069 2,270 2,468
Restricted cash
606 606 606 606
Other assets
504 523 542 561
Total assets
208,511 145,842 187,350 149,988
Accounts payable
8,576 5,216 11,100 4,169
Accrued expenses
38,123 58,474 32,865 21,351
Operating lease liabilities, current
1,058 1,105 1,151 1,129
Total current liabilities
47,757 64,795 45,116 26,649
Operating lease liabilities
2,721 2,962 3,196 3,485
Total liabilities
50,478 67,757 48,312 30,134
Preferred stock 0.001 par value per share 5,000,000 shares authorizedas of march 31, 2026 and december 31, 2025 500,000 and 250,000 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
1 ---
Common stock, 0.001 par value per share 115,000,000 shares authorized as of march 31, 2026 and december 31, 2025 103,882,937 and 83,090,392 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
103 83 86 64
Additional paid-in capital
622,367 512,779 511,219 444,420
Accumulated deficit
-464,444 -434,831 -372,333 -324,621
Accumulated other comprehensive gain
6 54 66 -9
Total stockholders equity
158,033 78,085 139,038 119,854
Total liabilities and stockholders equity
208,511 145,842 187,350 149,988
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$177,913K Marketable securities$22,472K Prepaid expenses andother current assets$4,592K Fixed assets, gross$2,515K Total current assets$204,977K Operating leaseright-of-use assets$1,866K Restricted cash$606K Property and equipment,net$558K Other assets$504K Less accumulateddepreciation$1,957K Total assets$208,511K Total liabilities andstockholders equity$208,511K Total stockholdersequity$158,033K Total liabilities$50,478K Accumulated deficit-$464,444K Additional paid-in capital$622,367K Total currentliabilities$47,757K Operating leaseliabilities$2,721K Common stock, 0.001 parvalue per share...$103K Accumulated othercomprehensive gain$6K Preferred stock 0.001 parvalue per share...$1K Accrued expenses$38,123K Accounts payable$8,576K Operating leaseliabilities, current$1,058K

Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR)